Latest current cash for APLT: $12M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Applied Therapeutics (APLT) currently reports a current cash of $12M as of September 2025. That compares with $99M in the prior-year period — down 87.9% year over year. Use the charts on this page to explore Applied Therapeutics's current cash history and peer comparisons.
Applied Therapeutics's current cash decreased from $99M to $12M — a 87.9% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Applied Therapeutics reported $12M in current cash as of September 2025. That compares with $99M in the prior-year period — down 87.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Therapeutics, and consider following APLT for alerts when major investors trade the stock.
Applied Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APLT with unrelated industries.